Open AccessCannabinoids and COVID-19
Author(s) -
El Biali Myriam,
Broers Barbara,
Besson Marie,
Demeules Jules
Publication year - 2020
Publication title -
medical cannabis and cannabinoids
Language(s) - English
Resource type - Journals
ISSN - 2504-3889
DOI - 10.1159/000510799
Subject(s) - commentary
Since the endocannabinoid system is involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. Some data suggest that the immunomodulatory effect of cannabinoids may affect the course and severity of SARS-CoV-2 infection. Given the large number of cannabinoids consumers in the community, this commentary presents the current knowledge on the potential impact of cannabinoids and endocannabinoids on bacterial and viral infection courses namely SARS-CoV-2 disease. Practical recommendations, which can be drawn from the literature, are given.